Results 21 to 30 of about 11,040 (158)

Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer

open access: yesBJS (British Journal of Surgery), Volume 107, Issue 8, Page 1053-1061, July 2020., 2020
Conditional survival accounts for the time already survived after surgery and may be of additional informative value. A nomogram was constructed that predicts 5‐year survival of patients with oesophageal cancer after neoadjuvant treatment followed by surgery, based on cardiac co‐morbidity, cN category, ypTN stage, chyle leakage and pulmonary ...
E. R. C. Hagens   +6 more
wiley   +1 more source

Impact of postoperative complications on survival after oesophagectomy for oesophageal cancer

open access: yesBJS Open, Volume 4, Issue 3, Page 405-415, June 2020., 2020
Recent evidence suggests that complications following oesophagectomy may decrease short‐ and long‐term survival. In this study, Clavien–Dindo grade II and IV complications decreased overall and recurrence‐free survival in univariable and multivariable Cox regression analyses.
J. R. Bundred   +5 more
wiley   +1 more source

Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery

open access: yesBJS Open, Volume 4, Issue 3, Page 424-431, June 2020., 2020
A nationwide prospective register‐based study examined the extent of lymphadenectomy in curative gastric cancer surgery and its effects on long‐term survival. More evidence in favour of thorough lymphadenectomy Background Gastrectomy including D2 lymphadenectomy is regarded as the standard curative treatment for advanced gastric cancer in Asia.
C.‐H. Kung   +5 more
wiley   +1 more source

Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma

open access: yesBJS Open, Volume 4, Issue 3, Page 416-423, June 2020., 2020
The neutrophil to lymphocyte ratio, dichotomized at 2·25, was strongly associated with Mandard tumour regression grade in patients who had neoadjuvant chemotherapy for oesophageal adenocarcinoma. The systemic inflammatory response may offer a novel therapeutic target for patients at risk of poor response.
A. G. M. T. Powell   +6 more
wiley   +1 more source

UEG Week 2021 Moderated Posters

open access: yes, 2021
United European Gastroenterology Journal, Volume 9, Issue S8, Page 163-259, October 2021.
wiley   +1 more source

Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study

open access: yesBJS Open, Volume 4, Issue 1, Page 59-70, February 2020., 2020
After oesophagectomy for oesophageal adenocarcinoma (OAC), the 5‐year survival rate is currently only 30 per cent. There is strong observational evidence that statin use is associated with reduced all‐cause and cancer‐specific mortality in patients with OAC.
L. Alexandre   +16 more
wiley   +1 more source

Expresión de regiones organizadoras nucleolares en epitelio de mucosa de esófago y estómago en ratones CF-1 expuestos a 4-nitroquinolina-1-oxido y ratones no expuestos [PDF]

open access: yes, 2010
79 p.INTRODUCCIÓN: A nivel mundial, el cáncer de esófago y estómago ocupan el sexto y cuarto lugar respectivamente entre las neoplasias más comunes. En el estudio del cáncer, los modelos de carcinogénesis experimental en animales, acordes al medio local,
Elizalde Ramírez, María de los Angeles   +1 more
core  

Repeated endoscopic ultrasound‐guided fine‐needle biopsy of solid pancreatic lesions after previous nondiagnostic or inconclusive sampling

open access: yesDigestive Endoscopy, Volume 36, Issue 5, Page 615-624, May 2024.
Objectives Repeated endoscopic ultrasound (EUS)‐guided tissue acquisition represents the standard practice for solid pancreatic lesions after previous nondiagnostic or inconclusive results. Since data are lacking, we aimed to evaluate the diagnostic performance of repeated EUS fine‐needle biopsy (rEUS‐FNB) in this setting.
Andrea Lisotti   +76 more
wiley   +1 more source

Intubación en el cáncer de esófago

open access: yesCirugía del Uruguay, 2020
Presentado en sesión de 20 de abril de ...
Félix E Leborgne, Luis A Barlocci
doaj  

Perfil dos Pacientes com Câncer de Esôfago Diagnosticados entre 2001 e 2010 no Brasil

open access: yesRevista Brasileira de Cancerologia, 2018
Introdução: O câncer de esôfago é a terceira neoplasia mais comum do trato digestivo e apresenta prognóstico ruim quando diagnosticado em estádios avançados da doença. Objetivo: Descrever as características sociodemográficas, clínicas e de tratamento dos
Ariane Igreja Buccos Marinho Cruz   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy